These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36945596)

  • 1. FAM122A ensures cell cycle interphase progression and checkpoint control as a SLiM-dependent substrate-competitive inhibitor to the B55⍺/PP2A phosphatase.
    Wasserman JS; Faezov B; Patel KR; Kurimchak AN; Palacio SM; Fowle H; McEwan BC; Xu Q; Zhao Z; Cressey L; Johnson N; Duncan JS; Kettenbach AN; Dunbrack RL; Graña X
    bioRxiv; 2023 Mar; ():. PubMed ID: 36945596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs.
    Wasserman JS; Faezov B; Patel KR; Kurimchak AM; Palacio SM; Glass DJ; Fowle H; McEwan BC; Xu Q; Zhao Z; Cressey L; Johnson N; Duncan JS; Kettenbach AN; Dunbrack RL; Graña X
    Nat Commun; 2024 Jul; 15(1):5776. PubMed ID: 38982062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PP2A/B55α substrate recruitment as defined by the retinoblastoma-related protein p107.
    Fowle H; Zhao Z; Xu Q; Wasserman JS; Wang X; Adeyemi M; Feiser F; Kurimchak AN; Atar D; McEwan BC; Kettenbach AN; Page R; Peti W; Dunbrack RL; Graña X
    Elife; 2021 Oct; 10():. PubMed ID: 34661528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of p107 by fibroblast growth factor, which is essential for chondrocyte cell cycle exit, is mediated by the protein phosphatase 2A/B55α holoenzyme.
    Kurimchak A; Haines DS; Garriga J; Wu S; De Luca F; Sweredoski MJ; Deshaies RJ; Hess S; Graña X
    Mol Cell Biol; 2013 Aug; 33(16):3330-42. PubMed ID: 23775125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The B55α regulatory subunit of protein phosphatase 2A mediates fibroblast growth factor-induced p107 dephosphorylation and growth arrest in chondrocytes.
    Kolupaeva V; Daempfling L; Basilico C
    Mol Cell Biol; 2013 Aug; 33(15):2865-78. PubMed ID: 23716589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAM122A, a new endogenous inhibitor of protein phosphatase 2A.
    Fan L; Liu MH; Guo M; Hu CX; Yan ZW; Chen J; Chen GQ; Huang Y
    Oncotarget; 2016 Sep; 7(39):63887-63900. PubMed ID: 27588481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanism of PP2A/B55α Phosphatase Inhibition by IER5.
    Cao R; Jones DT; Pan L; Yang A; Wang S; Padi SKR; Rawson S; Aster JC; Blacklow SC
    bioRxiv; 2024 Aug; ():. PubMed ID: 37693604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHK1 Inhibitor Blocks Phosphorylation of FAM122A and Promotes Replication Stress.
    Li F; Kozono D; Deraska P; Branigan T; Dunn C; Zheng XF; Parmar K; Nguyen H; DeCaprio J; Shapiro GI; Chowdhury D; D'Andrea AD
    Mol Cell; 2020 Nov; 80(3):410-422.e6. PubMed ID: 33108758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt.
    Kuo YC; Huang KY; Yang CH; Yang YS; Lee WY; Chiang CW
    J Biol Chem; 2008 Jan; 283(4):1882-92. PubMed ID: 18042541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol to assess substrate dephosphorylation by serine/threonine phosphoprotein phosphatases in vitro.
    Wasserman JS; Feiser F; Palacio S; Patel K; Gonzalez J; Fowle H; Graña X
    STAR Protoc; 2023 Apr; 4(2):102148. PubMed ID: 37074907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increases in cyclin A/Cdk activity and in PP2A-B55 inhibition by FAM122A are key mitosis-inducing events.
    Lacroix B; Vigneron S; Labbé JC; Pintard L; Lionne C; Labesse G; Castro A; Lorca T
    EMBO J; 2024 Mar; 43(6):993-1014. PubMed ID: 38378890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure- and modeling-based identification of the adenovirus E4orf4 binding site in the protein phosphatase 2A B55α subunit.
    Horowitz B; Sharf R; Avital-Shacham M; Pechkovsky A; Kleinberger T
    J Biol Chem; 2013 May; 288(19):13718-27. PubMed ID: 23530045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the adenovirus E4orf4 protein binding site on the B55α and Cdc55 regulatory subunits of PP2A: Implications for PP2A function, tumor cell killing and viral replication.
    Mui MZ; Kucharski M; Miron MJ; Hur WS; Berghuis AM; Blanchette P; Branton PE
    PLoS Pathog; 2013; 9(11):e1003742. PubMed ID: 24244166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryo-EM structures of PP2A:B55-FAM122A and PP2A:B55-ARPP19.
    Padi SKR; Vos MR; Godek RJ; Fuller JR; Kruse T; Hein JB; Nilsson J; Kelker MS; Page R; Peti W
    Nature; 2024 Jan; 625(7993):195-203. PubMed ID: 38123684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryo-EM structures of PP2A:B55-FAM122A and PP2A:B55-ARPP19.
    Padi SKR; Vos MR; Godek RJ; Fuller JR; Kruse T; Hein JB; Nilsson J; Kelker MS; Page R; Peti W
    bioRxiv; 2023 Aug; ():. PubMed ID: 37693408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer.
    Fowle H; Zhao Z; Graña X
    Adv Cancer Res; 2019; 144():55-93. PubMed ID: 31349904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of the Eya and PP2A-B55α interaction.
    Alderman C; Anderson R; Zhang L; Hughes CJ; Li X; Ebmeier C; Wagley ME; Ahn NG; Ford HL; Zhao R
    J Biol Chem; 2024 Jul; 300(7):107408. PubMed ID: 38796066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein interactomes of protein phosphatase 2A B55 regulatory subunits reveal B55-mediated regulation of replication protein A under replication stress.
    Wang F; Zhu S; Fisher LA; Wang W; Oakley GG; Li C; Peng A
    Sci Rep; 2018 Feb; 8(1):2683. PubMed ID: 29422626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of polo-like kinase 1 by DNA damage and PP2A/B55α.
    Wang L; Guo Q; Fisher LA; Liu D; Peng A
    Cell Cycle; 2015; 14(1):157-66. PubMed ID: 25483054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAM122A supports the growth of hepatocellular carcinoma cells and its deletion enhances Doxorubicin-induced cytotoxicity.
    Zhou Y; Shi WY; He W; Yan ZW; Liu MH; Chen J; Yang YS; Wang YQ; Chen GQ; Huang Y
    Exp Cell Res; 2020 Feb; 387(1):111714. PubMed ID: 31711919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.